Joseph Ross

Professor

Yale University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joseph Ross is a Professor at Yale University School of Medicine in the United States. His research primarily focuses on therapeutic outcomes related to drug approvals, comparative effectiveness of diabetes therapies, and the utilization of clinical trial data. Recent publications highlight his work on drug pricing, remote patient monitoring, and the impact of expedited FDA programs on drug development timelines.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Ravi Gupta

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Guillermo Umpierrez

Professor of Medicine

Emory University School of Medicine

UNITED STATES

View details

Rozalina McCoy

Associate Professor of Medicine

University of Maryland School of Medicine

UNITED STATES

View details

Carlo Castellani

Head of Cystic Fibrosis Center

Istituto Giannina Gaslini

ITALY

View details

Matthew Herder

Dalhousie University

CANADA

View details

Anisa Rowhani-Farid

University of Maryland School of Pharmacy

UNITED STATES

View details

Jeph Herrin

Yale University

UNITED STATES

View details

Kanhai Amin

Yale University

UNITED STATES

View details

Alberto Ruano-Ravina

Full Professor

Universidade de Santiago de Compostela

SPAIN

View details

Cristina Candal-Pedreira

Assistant professor

Universidade de Santiago de Compostela

SPAIN

View details

Sanket S. Dhruva

University of California

UNITED STATES

View details

Bishal Gyawali

Queen's University

CANADA

View details

Nihar R. Desai

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joseph Ross

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Use of FDA Expedited Programs and Development Timelines for New Molecular Entity Drug and New Biologic Approvals by Sponsor Experience

Flexibility Over Rigor: Stakeholder Acceptance of the Limitations of Confirmatory Studies Following Accelerated Approval

Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial

Heterogeneity of Cardiovascular Effects of Second‐Line Glucose‐Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk

Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid

On a Slow Boat to Publication: Rethinking How We Disseminate Medical Research

Reusing clinical trial data to consolidate and advance medical knowledge

Reforming the Prescription Drug User Fee Program

National Patterns of Remote Patient Monitoring Service Availability at US Hospitals

Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023)

Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data

Class I Recalls of Cardiovascular Devices Between 2013 and 2022

Feasibility of using real-world data to emulate substance use disorder clinical trials: a cross-sectional study

Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union

Retracted papers originating from paper mills: a cross-sectional analysis of references and citations

Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies

Funding of evidence included within public comments submitted to inform Medicare national coverage determinations

Biomedical retractions due to misconduct in Europe: characterization and trends in the last 20 years

Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy

Utilization of Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid From 2016 to 2020

The Accelerated Approval Program for Cancer Drugs — Finding the Right Balance

Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014

Payer-Negotiated Prices for Cardiac Electrophysiology Procedures at 2022-2023 Top 100 US News & World Report for Cardiology and Heart Surgery Hospitals

Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models

Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial

US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics

Challenges and solutions to advancing health equity with medical devices

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

Ensuring Public Trust in an Empowered FDA

Collaborators (13)

Ravi Gupta

Guillermo Umpierrez

Rozalina McCoy

Carlo Castellani

Matthew Herder

Anisa Rowhani-Farid

Jeph Herrin

Kanhai Amin

Alberto Ruano-Ravina

Cristina Candal-Pedreira

Sanket S. Dhruva

Bishal Gyawali

Nihar R. Desai

Make your next move.